Laura Wiley
University of York
11 Papers
11 Citations
Laura Wiley is an academic researcher from University of York. The author has contributed to research in topics: Randomized controlled trial & Population. The author has an hindex of 4, co-authored 6 publications. Previous affiliations of Laura Wiley include Newcastle University.
Chat about Author
Papers
Gender and telomere length : systematic review and meta-analysis
Michael P. Gardner,David Bann,Laura Wiley,Rachel Cooper,Rebecca Hardy,Dorothea Nitsch,Carmen Martin-Ruiz,Paul G. Shiels,Avan Aihie Sayer,Michelangela Barbieri,Sofie Bekaert,Claus Bischoff,Angela Brooks-Wilson,Wei Chen,Cyrus Cooper,Kaare Christensen,Tim De Meyer,Ian J. Deary,Geoff Der,Ana V. Diez Roux,Annette L. Fitzpatrick,Anjum Hajat,Julius Halaschek-Wiener,Sarah E. Harris,Steven C. Hunt,Carol Jagger,Hyo Sung Jeon,Robert C. Kaplan,Masayuki Kimura,Peter M. Lansdorp,Changyong Li,Toyoki Maeda,Massimo Mangino,Tim S. Nawrot,Peter M. Nilsson,Katarina Nordfjäll,Giuseppe Paolisso,Fu Ren,Karl Riabowol,Tony Robertson,Göran Roos,Jan A. Staessen,Tim D. Spector,Nelson L.S. Tang,Brad M. Unryn,Pim van der Harst,Jean Woo,Chao Xing,Mohammad E Yadegarfar,Jae Yong Park,Neal S. Young,Diana Kuh,Thomas von Zglinicki,Yoav Ben-Shlomo +53 more
TL;DR: Telomere length is longer in females than males, although this difference was not universally found in studies that did not use Southern blot methods, and further research on explanations for the methodological differences is required.
478
Assessment of a large panel of candidate biomarkers of ageing in the Newcastle 85+ study.
Carmen Martin-Ruiz,Carol Jagger,Andrew Kingston,Joanna Collerton,Michael Catt,Karen Davies,Mick Dunn,Catharien M. U. Hilkens,Bernard Keavney,Simon H. S. Pearce,Wendy P. J. den Elzen,Duncan Talbot,Laura Wiley,John Bond,John C. Mathers,Martin P Eccles,Louise Robinson,Oliver F. W. James,Thomas B. L. Kirkwood,Thomas von Zglinicki +19 more
TL;DR: Assessment of a large panel of candidate biomarkers in a cohort of 85 years old by studying comparative associations with health status found several proposed biomarkers of ageing, notably inflammation and immune risk markers and telomere length, did not have a predictive value.
128
Reactive oxygen species production and mitochondrial dysfunction in white blood cells are not valid biomarkers of ageing in the very old.
Laura Wiley,Deepthi Ashok,Carmen Martin-Ruiz,Duncan Talbot,Joanna Collerton,Andrew Kingston,Karen Davies,Patrick F. Chinnery,Michael Catt,Carol Jagger,Thomas B. L. Kirkwood,Thomas von Zglinicki +11 more
TL;DR: No associations were found between the measured parameters and age-related outcomes, including cognitive impairment, disability, co-morbidity and survival - questioning the validity of these parameters as candidate BoA in the very old.
Yoga for older adults with multimorbidity (the Gentle Years Yoga Trial): study protocol for a randomised controlled trial.
Garry A. Tew,Garry A. Tew,Laura J L Bissell,Belen Corbacho,Caroline Fairhurst,Jenny Howsam,Jess Hugill-Jones,Camila Maturana,Shirley-Anne S. Paul,Tim Rapley,Jenny Roche,Fi Rose,David J. Torgerson,Lesley Ward,Lesley Ward,Laura Wiley,David Yates,Catherine Hewitt +17 more
TL;DR: The British Wheel of Yoga's Gentle Years Yoga (GYY) programme was developed specifically for older adults, including those with chronic medical conditions as mentioned in this paper, but its effectiveness and cost-effectiveness remain uncertain.
A 2x2 randomised factorial SWAT of the use of a pen and small, financial incentive to improve recruitment in a randomised controlled trial of yoga for older adults with multimorbidity
Caroline Fairhurst,J. Roche,Laura Bissell,Catherine Hewitt,Jess Hugill-Jones,Jenny Howsam,Camila Maturana,Belen Corbacho Martin,Shirley-Anne S. Paul,Finnley A. Rose,David J. Torgerson,Lesley Ward,Laura Wiley,Garry A. Tew +13 more
TL;DR: A small, monetary incentive did not result in more participants being randomised into the host trial but did encourage increased and faster response to the recruitment invitation, and pens were cheaper but did not provide evidence of benefit.
9